Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Share:

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2022, Vol. 27 ›› Issue (7): 834-840.doi: 10.12092/j.issn.1009-2501.2022.07.015

Previous Articles     Next Articles

New narcotic analgesics: esketamine

JIA Tao1,2, TENG Jinliang2   

  1. 1 Graduate School of Hebei North University, Zhangjiakou 075000, Hebei, China; 2 Department of Anesthesiology, The First Affiliated Hospital of Hebei North University, Zhangjiakou 075000, Hebei, China

  • Received:2022-04-11 Revised:2022-07-05 Online:2022-07-26 Published:2022-08-11

Abstract: Esketamine is an excellent anesthetic with higher potency than ketamine, fast onset of action, rapid elimination from the body, mild respiratory depression, and little impact on the circulatory system. It has unique advantages in the field of clinical anesthesia and analgesia. Its sub-anesthetic dose regimen is the most widely used in various surgeries and short examinations. Compared with traditional ketamine, the dose required for anesthesia effect and mental side effects are lower, and the analgesic effect is stronger. It has great clinical application prospects.

Key words: esketamine, anesthesia, sedation, pain treatment

CLC Number: